Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-18
Journal	Expert Opinion on Pharmacotherapy
Volume	11
Issue number	15
DOIs	https://doi.org/10.1517/14656566.2010.502529
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{bb4f6254742f46388d522bbf38cb1fb5,

title = "Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies",

author = "Dick Chan and Gerald Watts",

year = "2011",

doi = "10.1517/14656566.2010.502529",

language = "English",

volume = "11",

pages = "1--18",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",

publisher = "Informa Healthcare USA",

number = "15",

}

TY - JOUR

T1 - Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies

AU - Chan, Dick

AU - Watts, Gerald

PY - 2011

Y1 - 2011

U2 - 10.1517/14656566.2010.502529

DO - 10.1517/14656566.2010.502529

M3 - Article

C2 - 20629587

VL - 11

SP - 1

EP - 18

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 15

ER -